Insider Selling: comScore (NASDAQ:SCOR) Director Sells 9,900 Shares of Stock

comScore, Inc. (NASDAQ:SCOR) Director William Paul Livek sold 9,900 shares of the company’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $6.55, for a total transaction of $64,845.00. Following the transaction, the director directly owned 187,473 shares in the company, valued at approximately $1,227,948.15. This trade represents a 5.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

William Paul Livek also recently made the following trade(s):

• On Wednesday, November 12th, William Paul Livek sold 2,002 shares of comScore stock. The shares were sold at an average price of $6.85, for a total transaction of $13,713.70.
• On Tuesday, November 11th, William Paul Livek sold 3,735 shares of comScore stock. The stock was sold at an average price of $7.12, for a total transaction of $26,593.20.
• On Monday, November 10th, William Paul Livek sold 2,206 shares of comScore stock. The shares were sold at an average price of $7.57, for a total transaction of $16,699.42.

comScore Stock Up 2.7%

NASDAQ SCOR traded up $0.17 during mid-day trading on Monday, hitting $6.60. The stock had a trading volume of 7,660 shares, compared to its average volume of 30,653. The company has a 50 day simple moving average of $7.22 and a 200 day simple moving average of $6.08. The company has a market cap of $33.13 million, a price-to-earnings ratio of -0.38 and a beta of 1.20. comScore, Inc. has a 52-week low of $4.39 and a 52-week high of $10.18.

Institutional Trading of comScore

Several institutional investors and hedge funds have recently made changes to their positions in SCOR. Westerly Capital Management LLC increased its position in comScore by 1.3% during the 2nd quarter. Westerly Capital Management LLC now owns 400,000 shares of the company’s stock worth $1,928,000 after purchasing an additional 5,000 shares in the last quarter. Covestor Ltd purchased a new stake in shares of comScore during the third quarter worth about $91,000. Citadel Advisors LLC acquired a new position in shares of comScore in the third quarter valued at approximately $96,000. Finally, Susquehanna International Group LLP lifted its stake in shares of comScore by 15.3% during the third quarter. Susquehanna International Group LLP now owns 39,064 shares of the company’s stock valued at $341,000 after buying an additional 5,191 shares during the period. 42.15% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of comScore in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

comScore Company Profile

comScore, Inc operates as an information and analytics company that measures audiences, consumer behavior, and advertising across media platforms in the United States, Europe, Latin America, Canada, and internationally. The company provides digital ad solutions, including Media Metrix Multi-Platform and Mobile Metrix, which measure websites and applications on computers, smartphones, and tablets; Video Metrix that delivers measurement of digital video consumption; Plan Metrix, which offers understanding of consumer lifestyle; Total Home Panel Suite, which capture OTT, connected TV, and IOT device usage and content consumption; CCR, which enhances validated campaign essentials verification of mobile and desktop video campaigns; XMedia Enhanced, which provides a deduplicated view of national programming content; Comscore marketing solutions; Lift Models, which measures the impact of advertising on a brand; Survey Analytics, which measure various consumer insights including brand health metrics; and Activation Solutions, including audience activation and content activation.